 Allison Shapiro
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Feeding Behavior | 5 | 2026 | 689 | 1.990 |
Why?
| | Adiposity | 9 | 2022 | 532 | 1.610 |
Why?
| | Maternal Nutritional Physiological Phenomena | 5 | 2023 | 178 | 1.400 |
Why?
| | Cynara scolymus | 1 | 2026 | 3 | 0.950 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2578 | 0.950 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2025 | 159 | 0.930 |
Why?
| | Obesity | 9 | 2022 | 3097 | 0.890 |
Why?
| | Hypothalamus | 1 | 2026 | 163 | 0.890 |
Why?
| | Cognition | 8 | 2024 | 1262 | 0.880 |
Why?
| | Caregivers | 2 | 2025 | 1070 | 0.860 |
Why?
| | Family Characteristics | 2 | 2025 | 195 | 0.850 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2024 | 650 | 0.830 |
Why?
| | Diet | 6 | 2025 | 1277 | 0.780 |
Why?
| | Insulin Resistance | 3 | 2024 | 1244 | 0.770 |
Why?
| | Overweight | 2 | 2020 | 609 | 0.750 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 55 | 0.740 |
Why?
| | Language Development | 2 | 2024 | 59 | 0.740 |
Why?
| | Obesity, Morbid | 1 | 2026 | 289 | 0.710 |
Why?
| | Insulin | 5 | 2024 | 2510 | 0.700 |
Why?
| | Executive Function | 3 | 2024 | 469 | 0.690 |
Why?
| | Hunger | 2 | 2019 | 56 | 0.690 |
Why?
| | Birth Weight | 10 | 2024 | 513 | 0.680 |
Why?
| | Pediatric Obesity | 4 | 2026 | 637 | 0.670 |
Why?
| | Prediabetic State | 1 | 2024 | 247 | 0.660 |
Why?
| | Mothers | 5 | 2024 | 764 | 0.630 |
Why?
| | Blood Glucose | 6 | 2022 | 2335 | 0.600 |
Why?
| | Adipogenesis | 2 | 2016 | 56 | 0.580 |
Why?
| | Umbilical Cord | 3 | 2017 | 92 | 0.530 |
Why?
| | Niacin | 1 | 2017 | 16 | 0.520 |
Why?
| | Brain | 2 | 2020 | 2934 | 0.500 |
Why?
| | Reward | 1 | 2019 | 248 | 0.480 |
Why?
| | Body Composition | 6 | 2017 | 690 | 0.480 |
Why?
| | Niacinamide | 1 | 2016 | 87 | 0.460 |
Why?
| | Diet, High-Fat | 1 | 2017 | 266 | 0.460 |
Why?
| | Pregnancy | 17 | 2024 | 7182 | 0.460 |
Why?
| | Magnetic Resonance Imaging | 3 | 2026 | 3892 | 0.420 |
Why?
| | Child, Preschool | 12 | 2025 | 11835 | 0.410 |
Why?
| | Body Mass Index | 11 | 2024 | 2437 | 0.390 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 305 | 0.380 |
Why?
| | Infant | 11 | 2026 | 10060 | 0.380 |
Why?
| | Female | 30 | 2026 | 78636 | 0.380 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2023 | 3918 | 0.340 |
Why?
| | Cannabidiol | 2 | 2024 | 142 | 0.340 |
Why?
| | Health Behavior | 1 | 2017 | 787 | 0.340 |
Why?
| | Male | 21 | 2026 | 72664 | 0.320 |
Why?
| | Humans | 34 | 2026 | 145140 | 0.320 |
Why?
| | Cannabinoids | 2 | 2023 | 184 | 0.310 |
Why?
| | Adult | 17 | 2026 | 40665 | 0.310 |
Why?
| | Cohort Studies | 6 | 2021 | 5988 | 0.310 |
Why?
| | Infant, Newborn | 11 | 2024 | 6435 | 0.310 |
Why?
| | Child Development | 3 | 2024 | 483 | 0.290 |
Why?
| | Plethysmography | 4 | 2017 | 104 | 0.290 |
Why?
| | Diet Surveys | 3 | 2017 | 90 | 0.280 |
Why?
| | Biomarkers | 1 | 2019 | 4282 | 0.260 |
Why?
| | Longitudinal Studies | 6 | 2024 | 2949 | 0.260 |
Why?
| | Cognition Disorders | 2 | 2024 | 539 | 0.260 |
Why?
| | Language | 2 | 2022 | 322 | 0.260 |
Why?
| | Adolescent | 9 | 2026 | 22479 | 0.240 |
Why?
| | Child | 9 | 2024 | 22670 | 0.230 |
Why?
| | Cannabis | 2 | 2023 | 509 | 0.220 |
Why?
| | Single-Blind Method | 1 | 2026 | 316 | 0.220 |
Why?
| | PPAR gamma | 2 | 2016 | 178 | 0.220 |
Why?
| | Young Adult | 9 | 2024 | 14176 | 0.220 |
Why?
| | Diabetic Neuropathies | 2 | 2023 | 100 | 0.220 |
Why?
| | Cross-Over Studies | 1 | 2026 | 608 | 0.200 |
Why?
| | Glucose Tolerance Test | 1 | 2024 | 360 | 0.190 |
Why?
| | Prospective Studies | 6 | 2023 | 8035 | 0.180 |
Why?
| | Vocabulary | 1 | 2022 | 33 | 0.180 |
Why?
| | Dronabinol | 1 | 2024 | 249 | 0.170 |
Why?
| | Educational Status | 1 | 2024 | 465 | 0.170 |
Why?
| | Follow-Up Studies | 2 | 2024 | 5411 | 0.170 |
Why?
| | Diabetes Complications | 1 | 2023 | 224 | 0.170 |
Why?
| | Food | 1 | 2022 | 150 | 0.170 |
Why?
| | Weight Gain | 2 | 2015 | 561 | 0.170 |
Why?
| | Hallucinogens | 1 | 2023 | 111 | 0.160 |
Why?
| | Colorado | 7 | 2019 | 4538 | 0.160 |
Why?
| | Maternal Inheritance | 1 | 2020 | 15 | 0.160 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 265 | 0.150 |
Why?
| | Insulin-Secreting Cells | 1 | 2024 | 392 | 0.150 |
Why?
| | Hyperphagia | 1 | 2019 | 38 | 0.140 |
Why?
| | Energy Intake | 2 | 2023 | 507 | 0.130 |
Why?
| | Maternal Exposure | 1 | 2019 | 188 | 0.130 |
Why?
| | Fasting | 1 | 2019 | 276 | 0.130 |
Why?
| | Satiation | 1 | 2017 | 26 | 0.130 |
Why?
| | Tobacco Smoke Pollution | 1 | 2019 | 227 | 0.130 |
Why?
| | Dietary Supplements | 1 | 2021 | 582 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 465 | 0.120 |
Why?
| | Regression Analysis | 1 | 2019 | 998 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5886 | 0.120 |
Why?
| | Sirtuin 1 | 1 | 2016 | 34 | 0.120 |
Why?
| | Neurodevelopmental Disorders | 1 | 2019 | 226 | 0.120 |
Why?
| | Infant, Small for Gestational Age | 1 | 2017 | 118 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 192 | 0.120 |
Why?
| | Fetal Development | 2 | 2016 | 298 | 0.120 |
Why?
| | Sense of Coherence | 1 | 2015 | 12 | 0.110 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 83 | 0.110 |
Why?
| | Dietary Carbohydrates | 1 | 2016 | 147 | 0.110 |
Why?
| | Socioeconomic Factors | 2 | 2017 | 1321 | 0.110 |
Why?
| | Fetal Blood | 1 | 2017 | 325 | 0.110 |
Why?
| | Dietary Proteins | 1 | 2016 | 135 | 0.110 |
Why?
| | Homeostasis | 1 | 2019 | 639 | 0.110 |
Why?
| | Prenatal Care | 1 | 2017 | 309 | 0.110 |
Why?
| | Lipids | 2 | 2021 | 706 | 0.110 |
Why?
| | Psychological Tests | 1 | 2015 | 130 | 0.110 |
Why?
| | Dietary Fats | 1 | 2016 | 308 | 0.100 |
Why?
| | Fatty Acids | 1 | 2017 | 457 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 847 | 0.100 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 1134 | 0.100 |
Why?
| | Vitamin D | 1 | 2017 | 403 | 0.100 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 170 | 0.100 |
Why?
| | beta Catenin | 1 | 2015 | 254 | 0.100 |
Why?
| | Linear Models | 4 | 2017 | 844 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1039 | 0.100 |
Why?
| | Risk Factors | 5 | 2021 | 10857 | 0.090 |
Why?
| | Gene Expression | 1 | 2017 | 1474 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1470 | 0.090 |
Why?
| | DNA Methylation | 1 | 2017 | 667 | 0.090 |
Why?
| | Parents | 1 | 2021 | 1401 | 0.090 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 6055 | 0.090 |
Why?
| | Indians, North American | 1 | 2015 | 598 | 0.080 |
Why?
| | Blood Pressure | 1 | 2017 | 1778 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 600 | 0.080 |
Why?
| | Breast Feeding | 2 | 2024 | 446 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2015 | 933 | 0.070 |
Why?
| | Muscle Development | 2 | 2017 | 112 | 0.060 |
Why?
| | Aged | 2 | 2024 | 26096 | 0.060 |
Why?
| | Exercise | 1 | 2017 | 2191 | 0.050 |
Why?
| | Middle Aged | 2 | 2024 | 36126 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2183 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 40 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2017 | 2040 | 0.040 |
Why?
| | Diabetic Retinopathy | 1 | 2021 | 209 | 0.030 |
Why?
| | United States | 1 | 2016 | 16065 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | Diabetic Nephropathies | 1 | 2021 | 319 | 0.030 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 49 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1048 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 83 | 0.030 |
Why?
| | Pregnancy Trimester, Third | 1 | 2017 | 118 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 145 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 74 | 0.030 |
Why?
| | Mental Recall | 1 | 2017 | 217 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 100 | 0.030 |
Why?
| | Health | 1 | 2015 | 82 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 290 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 529 | 0.030 |
Why?
| | Gestational Age | 1 | 2017 | 987 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1066 | 0.020 |
Why?
| | Leptin | 1 | 2015 | 248 | 0.020 |
Why?
| | Oral Health | 1 | 2015 | 139 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1546 | 0.020 |
Why?
| | Triglycerides | 1 | 2015 | 520 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2915 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 730 | 0.020 |
Why?
| | Self Efficacy | 1 | 2015 | 410 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2133 | 0.020 |
Why?
| | Psychometrics | 1 | 2015 | 731 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1351 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1163 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1763 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2014 | 644 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2588 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4142 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3410 | 0.020 |
Why?
| | Quality of Life | 1 | 2015 | 3194 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 8318 | 0.010 |
Why?
|
|
Shapiro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|